By product type
Laboratory Reagents
New Inhibitor Products
Compound Libraries
in vivo Antibodies
Biosimilar Antibodies
Natural Products
API
ADC
PROTAC
Peptides
Antibiotics
Kits
qPCR Master Mix
By research
Lung Cancer
Diabetes Mellitus
Immunology
Metabolism
Cell Death
Epigenetics
Liver Cancer
Breast Cancer
Ovarian Cancer
Cervical Cancer
Pancreatic Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Gliomas
Gastric Cancer
Anti-Aging
Alzheimer's Disease
Stem Cell
By Signaling Pathways
PI3K/Akt/mTOR
Epigenetics
Methylation
Immunology & Inflammation
Protein Tyrosine Kinase
Angiogenesis
Apoptosis
Autophagy
ER stress & UPR
JAK/STAT
MAPK
Cytoskeletal Signaling
Cell Cycle
TGF-beta/Smad
DNA Damage/DNA Repair
Stem Cells & Wnt
Hippo
Ubiquitin
Neuronal Signaling
NF-κB
GPCR & G Protein
Endocrinology & Hormones
Transmembrane Transporters
Metabolism
Proteases
Microbiology
Others

Selleck products have been cited in
over 60,000 studies

Since Jan 2010, Selleck products have been cited in studies from top scientific journals.

15 Nobel Prize winners have published 45 articles with Selleck products.
The Nobel Prize

Katalin Karikó

Won the Nobel Prize in Physiology or Medicine in 2023

David Julius

Won the Nobel Prize in Physiology or Medicine in 2021

Michael Houghton

Won the Nobel Prize in Physiology or Medicine in 2020

Charles M. Rice

Won the Nobel Prize in Physiology or Medicine in 2020

William G. Kaelin Jr

Won the Nobel Prize in Physiology or Medicine in 2019

Peter J. Ratcliffe

Won the Nobel Prize in Physiology or Medicine in 2019

Gregg L. Semenza

Won the Nobel Prize in Physiology or Medicine in 2019

James P. Allison

Won the Nobel Prize in Physiology or Medicine in 2018

Michael Rosbash

Won the Nobel Prize in Physiology or Medicine in 2017

Shinya Yamanaka

Won the Nobel Prize in Physiology or Medicine in 2012

Eric Richard Kandel

Won the Nobel Prize in Physiology or Medicine in 2000

Aziz Sancar

Won the Nobel Prize in Chemistry in 2015

Brian K. Kobilka

Won the Nobel Prize in Chemistry in 2012

Robert Lefkowitz

Won the Nobel Prize in Chemistry in 2012

Aaron Ciechanover

Won the Nobel Prize in Chemistry in 2004

Compound Libraries

FDA-approved Drug Library

A unique collection of 3109 approved drugs and API included in pharmacopoeia for high throughput screening (HTS) and high content screening (HCS).

FDA-approved & Passed Phase I Drug Library

A unique collection of 3621 drugs that are marketed around the world or have passed clinical phase 1 and can be used for high throughput screening (HTS) and high content screening (HCS).

Preclinical/Clinical Compound Library

A unique collection of 3474 preclinical and clinical compounds for high throughput screening (HTS) and high content screening (HCS).

Bioactive Compound Library-I

A unique collection of 9972 bioactive compounds for high throughput screening (HTS) and high content screening (HCS).

Bioactive Compound Library-Ⅱ

A unique collection of 5309 bioactive compounds for high throughput screening (HTS) and high content screening (HCS).

Kinase Inhibitor Library

A unique collection of 2014 kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

Express-Pick Library

A unique collection of 3010 chemical compounds featured different core structures and structural diversities respectively for high throughput screening (HTS) and high content screening (HCS).

Natural Product Library

A unique collection of 3061 natural products for high throughput screening (HTS) and high content screening (HCS).

Human Endogenous Metabolite Compound Library

847 small collections of human endogenous metabolites, involving multiple metabolic pathways, which can be used for high-throughput screening, opening up new ways for humans to treat various diseases such as tumors.

Alkaloid Compound Library

A unique collection of 440 alkaloid compounds used for high throughput screening(HTS) and high content screening(HCS).

Click to View More
New Products

G150

G150 is a potent and highly selective human cyclic GMP-AMP synthase (h-cGAS) inhibitor with IC50 of 10.2 nM.

TH5487

TH5487 is a selective active-site inhibitor of 8-oxoguanine DNA glycosylase 1 (OGG1) with IC50 of 342 nM.

KGA-2727

KGA-2727 is a potent, selective, high-affinity inhibitor of sodium glucose cotransporter 1 (SGLT1) with Ki of 97.4 nM and 43.5 nM for human SGLT1 and rat SGLT1, respectively. The selectivity ratios (Ki for SGLT2/Ki for SGLT1) of KGA-2727 are 140 (human) and 390 (rat). KGA-2727 exhibits antidiabetic efficacy in rodent models.

Mizagliflozin

Mizagliflozin is a novel, potent, selective sodium glucose co-transporter 1 (SGLT1) inhibitor with Ki of 27 nM for human SGLT1. The selectivity ratio (Ki value for human SGLT2/Ki value for human SGLT1) of mizagliflozin is 303. Mizagliflozin shows the potential use for the amelioration of chronic constipation.

Guadecitabine (SGI-110)

Guadecitabine (SGI-110) is a next-generation hypomethylating agent whose active metabolite decitabine has a longer in-vivo exposure time than intravenous decitabine.

CM272

CM-272 is a novel first-in-class dual reversible inhibitor of G9a (GLP) and DNMTs with IC50 of 8 nM, 382 nM, 85 nM, 1200 nM, 2 nM for G9a, DNMT1, DNMT3A, DNMT3B, GLP, respectively. CM-272 prolongs survival in in vivo models of haematological malignancies by at least in part inducing immunogenic cell death.

Visomitin (SKQ1)

INT-777 (S-EMCA) is a novel potent and selective TGR5 agonist with EC50 values of 0.18 μM, 3.9 μM and 1.45 μM for WT TGR5, TGR5(N76A) and TGR5(Y89F) respectively.

BAY1125976

BAY 1125976 is a selective allosteric AKT1/2 inhibitor,exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models. BAY1125976 inhibits the activity of AKT1 (IC50 = 5.2 nM at 10 µM ATP and 44 nM at 2 mM ATP) and AKT2 (IC50 = 18 nM at 10 µM ATP and 36 nM at 2 mM ATP) very potently.Whereas BAY1125976 is almost inactive on AKT3 (IC50 = 427 nM at 10 µM ATP).

Click to View More
Tags: kinase inhibitors, tyrosine kinase inhibitors, enzyme inhibitors, protein inhibitors, proteins kinase inhibitors, small molecules, phosphatase inhibitors